Mariner
VIR icon

Mariner’s Vir Biotechnology VIR Stock Holding History

Mariner’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$303K Sell
29,756
-6,281
-17% -$59.8K ﹤0.01% 2839
2026
Q1 		$323K Buy
+36,037
New +$287K ﹤0.01% 2801
2024
Q2 		– Sell
-10,971
Closed -$111K – 3294
2024
Q1 		$111K Sell
10,971
-7
-0.1% -$71 ﹤0.01% 2911
2023
Q4 		$110K Buy
+10,978
New +$100K ﹤0.01% 2840

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mariner's VIR Position: Q2 2026 in Review

Mariner reduced its Vir Biotechnology (VIR) stake by 17% in Q2 2026, selling an estimated $59.8K and leaving 29,756 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #2839.

Mariner first reported a position in VIR in Q4 2023 and has held it in 4 quarters since. The position peaked at $323K in Q1 2026. 238 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Mariner held 29,756 shares of Vir Biotechnology worth $303K as of Q2 2026.
  • Mariner sold 6,281 Vir Biotechnology shares in Q2 2026, an estimated $59.8K.
  • Vir Biotechnology made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2839 holding.
  • Mariner first reported a position in Vir Biotechnology in Q4 2023 and has held it in 4 quarters since.
  • Mariner's Vir Biotechnology position peaked at $323K in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.